Ligand · L0E
L0E · 4-[(2-{4-[(phenylcarbamoyl)amino]-1H-pyrazol-3-yl}-1H-benzimidazol-5-yl)methyl]morpholin-4-ium
L0E, 4-[(2-{4-[(phenylcarbamoyl)amino]-1H-pyrazol-3-yl}-1H-benzimidazol-5-yl)methyl]morpholin-4-ium (C22 H24 N7 O2 +1, 418.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its…
- Component
- L0E
- Formula
- C22 H24 N7 O2 +1
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
L0E in 2 structures; the first of them:
- 2W1E · Structure determination of Aurora Kinase in complex with inhibitor · L0E A1390 · binds ARG137, LEU139, GLY140, LYS141, VAL147, ALA160, LYS162, LEU194 and 10 more
- 2W1E · Structure determination of aurora kinase in complex with inhibitor · L0E A1390 · binds ARG137, LEU139, GLY140, LYS141, VAL147, ALA160, LYS162, LEU194 and 10 more
Residues it binds most
LEU 2, ALA 2, ARG 2, GLY 2, LYS 2, GLU 2, PRO 2, THR 2, TYR 2, VAL 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.